Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain

Prasad Cooray, Yuping Yuan, Simone M. Schoenwaelder, Christina A. Mitchell, Hatem H. Salem, Shaun P. Jackson

Research output: Contribution to journalArticleResearchpeer-review

153 Citations (Scopus)

Abstract

Focal adhesion kinase (125 kDa form; pp125FAK) is a widely expressed non-receptor tyrosine kinase that is implicated in integrin-mediated signal transduction. We have identified a novel means of pp125FAK regulation in human platelets, in which this kinase undergoes sequential proteolytic modification from the native 125 kDa form to 90, 45 and 40 kDa fragments in thrombin-, collagen- and ionophore A23187-stimulated platelets. The proteolysis of pp125FAK was prevented by pretreating platelets with the calpain inhibitors calpeptin or calpain inhibitor-1, and was reproduced in vitro by incubating immunoprecipitated pp125FAK with purified calpain. Proteolysis of pp125FAK resulted in a dramatic reduction in its autokinase activity and led to its dissociation from the cytoskeletal fraction of platelets. These studies define a novel signal-terminating role for calpain, wherein proteolytic modification of pp125FAK attenuates its autokinase activity and induces its subcellular relocation within the cell.

Original languageEnglish
Pages (from-to)41-47
Number of pages7
JournalBiochemical Journal
Volume318
Issue number1
Publication statusPublished - 15 Aug 1996

Cite this

@article{083eabedd9a2471f924082c2e90c19cd,
title = "Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain",
abstract = "Focal adhesion kinase (125 kDa form; pp125FAK) is a widely expressed non-receptor tyrosine kinase that is implicated in integrin-mediated signal transduction. We have identified a novel means of pp125FAK regulation in human platelets, in which this kinase undergoes sequential proteolytic modification from the native 125 kDa form to 90, 45 and 40 kDa fragments in thrombin-, collagen- and ionophore A23187-stimulated platelets. The proteolysis of pp125FAK was prevented by pretreating platelets with the calpain inhibitors calpeptin or calpain inhibitor-1, and was reproduced in vitro by incubating immunoprecipitated pp125FAK with purified calpain. Proteolysis of pp125FAK resulted in a dramatic reduction in its autokinase activity and led to its dissociation from the cytoskeletal fraction of platelets. These studies define a novel signal-terminating role for calpain, wherein proteolytic modification of pp125FAK attenuates its autokinase activity and induces its subcellular relocation within the cell.",
author = "Prasad Cooray and Yuping Yuan and Schoenwaelder, {Simone M.} and Mitchell, {Christina A.} and Salem, {Hatem H.} and Jackson, {Shaun P.}",
year = "1996",
month = "8",
day = "15",
language = "English",
volume = "318",
pages = "41--47",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press",
number = "1",

}

Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain. / Cooray, Prasad; Yuan, Yuping; Schoenwaelder, Simone M.; Mitchell, Christina A.; Salem, Hatem H.; Jackson, Shaun P.

In: Biochemical Journal, Vol. 318, No. 1, 15.08.1996, p. 41-47.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain

AU - Cooray, Prasad

AU - Yuan, Yuping

AU - Schoenwaelder, Simone M.

AU - Mitchell, Christina A.

AU - Salem, Hatem H.

AU - Jackson, Shaun P.

PY - 1996/8/15

Y1 - 1996/8/15

N2 - Focal adhesion kinase (125 kDa form; pp125FAK) is a widely expressed non-receptor tyrosine kinase that is implicated in integrin-mediated signal transduction. We have identified a novel means of pp125FAK regulation in human platelets, in which this kinase undergoes sequential proteolytic modification from the native 125 kDa form to 90, 45 and 40 kDa fragments in thrombin-, collagen- and ionophore A23187-stimulated platelets. The proteolysis of pp125FAK was prevented by pretreating platelets with the calpain inhibitors calpeptin or calpain inhibitor-1, and was reproduced in vitro by incubating immunoprecipitated pp125FAK with purified calpain. Proteolysis of pp125FAK resulted in a dramatic reduction in its autokinase activity and led to its dissociation from the cytoskeletal fraction of platelets. These studies define a novel signal-terminating role for calpain, wherein proteolytic modification of pp125FAK attenuates its autokinase activity and induces its subcellular relocation within the cell.

AB - Focal adhesion kinase (125 kDa form; pp125FAK) is a widely expressed non-receptor tyrosine kinase that is implicated in integrin-mediated signal transduction. We have identified a novel means of pp125FAK regulation in human platelets, in which this kinase undergoes sequential proteolytic modification from the native 125 kDa form to 90, 45 and 40 kDa fragments in thrombin-, collagen- and ionophore A23187-stimulated platelets. The proteolysis of pp125FAK was prevented by pretreating platelets with the calpain inhibitors calpeptin or calpain inhibitor-1, and was reproduced in vitro by incubating immunoprecipitated pp125FAK with purified calpain. Proteolysis of pp125FAK resulted in a dramatic reduction in its autokinase activity and led to its dissociation from the cytoskeletal fraction of platelets. These studies define a novel signal-terminating role for calpain, wherein proteolytic modification of pp125FAK attenuates its autokinase activity and induces its subcellular relocation within the cell.

UR - http://www.scopus.com/inward/record.url?scp=0029840665&partnerID=8YFLogxK

M3 - Article

VL - 318

SP - 41

EP - 47

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 1

ER -